# Optimal Duration of Anticoagulation in Deep Venous Thrombosis

> **NCT01285661** · PHASE3 · COMPLETED · sponsor: **University of Padova** · enrollment: 584 (actual)

## Conditions studied

- Deep Vein Thrombosis of Lower Limb
- Lower Extremity Deep Venous Thrombosis Recurrent

## Interventions

- **DRUG:** Sodium warfarin

## Key facts

- **NCT ID:** NCT01285661
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 584 (ACTUAL)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285661, "Optimal Duration of Anticoagulation in Deep Venous Thrombosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01285661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*